Announcements

Therapeutic Drug Monitoring for Tofacitinib (Xeljanz®)

05/08/2015

NMS Labs offers a therapeutic drug monitoring (TDM) test for patients using tofacitinib. Tofacitinib is a Janus kinase (JAK) inhibitor indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. Information and insights obtained from the Test Results Report can be used to shorten the time needed to establish and maintain an optimal dosing regimen.

4489 Tofacitinib

« Return to News Listing